2.4 Exposure definition The primary exposure was GLP-1 RA use, defined as any documented prescription fill for a GLP-1 RA (liraglutide, semaglutide, exenatide, and dulaglutide) at least 90 days prior to the index date, based on prescription records in the electronic health record
This, in turn, they hypothesized, could reduce the potential for environmental damage that can eventually lead to skin cancer
Users who report that their compounded semaglutide is not working or that they have hit a semaglutide plateau should consider whether injection site issues might be contributing to inconsistent results
Laboratory investigations have demonstrated that ipamorelin exerts no influence on the release of ACTH, prolactin, follicle-stimulating hormone, luteinizing hormone, thyroid-stimulating hormone, or cortisol []